Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Mark Murakami
follicular lymphoma
Nicolas Nassar
pediatric leukemia
Daniel Lucas
bone marrow and leukemia biology
Philippe Armand
follicular lymphoma
Inhye Ahn
CLL
Pietro Genovese
transplant and AML
Omar Abdel-Wahab
Hairy cell leukemia
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Rong Lu
preleukemia, leukemia
Christine Zhang
AML
Lawrence Boise
CART and myeloma
Jonathon Cohen
lymphoma clinical trial access in Georgia
Jianhua Yu
myeloma immunotherapy
Manyi Wei
acute megakaryoblastic leukemia
Dimericon Therapeutics
dimericons, blood cancer
Jean Koff
Disparities in DLBCL
John Crispino
MPNs, myelofibrosis
Dane Vassiliadis
blood cancer biology
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Julia Paczkowska
immunobiology of Hodgkin's disease
Coleman Lindsley
AML/MDS
Shannon Maude
Immunotherapy for ALL
Suman Paul
T cell cancers and immunotherapy
Sahand Hormoz
MPN
Lev Kats
myeloma and epigenetics
Dan Landau
cancer evolution biology
Keisuke Ito
blood cancer stem cells and MDS metabolism
Reina Takeda
AML
Martin Dreyling
Mantle Cell Lymphoma
Constellation Pharmaceuticals
myeloproliferative neoplasms
Catherine Diefenbach
DLBCL immunology
Kasey Leger
pediatric blood cancers
Paolo Strati
Non-Hodgkin Lymphoma
Sam Butterworth
CMML
Nicola Vannini
Aging and CAR-T success
Areej El-Jawahri
transplant survivorship
Ravindra Majeti
preleukemia, AML
Sigurður Kristinsson
Smoldering myeloma
Suzanne Lentzsch
Myeloma
Caron Jacobson
lymphoma and immunotherapy
Wendy Béguelin
follicular lymphoma
Christopher Booth
BPDCN
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Cailin Collins
Leukemia and pre-leukemia
Andrew Lane
BPDCN
Eirini Papapetrou
blood cancer stem cells
Takeshi Sugio
T-cell lymphoma
Jeremy Baeten
AML
Marc Seifert
Hairy cell leukemia
Elliot Stieglitz
CMML
Abintus Bio
immunotherapy, in vivo CAR
Alex Kentsis
pediatric leukemias
Rajni Kumari
AML
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Anushree Vichare
Equity in Access
Luca Busino
DLBCL
Amit Verma
AML/MDS
Thomas Kipps
Hairy Cell Leukemia
Michael Green
lymphoma biology
Bing Carter
p53 mutant AML
Alfred Garfall
myeloma immunotherapy
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Caroline Arber
myeloma CAR-T
Jaehyuk Choi
T-cell lymphoma
Jessica Stewart
Epstein-barr virus and lymphomas
Catherine Bollard
pediatric blood cancers and immunotherapy
Robert Soiffer
transplantation
Kimberly Stegmaier
childhood blood cancers
Catriona Jamieson
cancer stem cell biology
Xu Ji
Equity in Access
Rizwan Romee
Immunotherapy
Eric Padron
CMML
Srividya Swaminathan
pediatric, immunotherapy
George Vassiliou
Leukemia Prevention
Joachim Yahalom
Lymphoma
Eugenio Morelli
Myeloma
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Tanya Siddiqi
clinical trial access
Jonas Jutzi
myeloproliferative neoplasms
Siegfried Janz
Myeloma immunotherapy
Helen Parsons
Equity in Access
Daniel Starczynowski
MDS and AML
Jalpa Doshi
Equity in Access
ImCheck Therapeutics
immunotherapy, AML
Trent Hall
MDS
Nataly Cruz-Rodriguez
T-ALL and metabolism
Nitin Jain
CLL
Michaela Reagan
Multiple Myeloma
Anthony Letai
improving CAR-T
Oreofe Odejide
Equity in Access
Courtney Jones
AML metabolism
BioInvent International
immunotherapy, indolent NHL, CTCL
Leandro Cerchietti
DLBCL
Yan Liu
MDS
Alison Moskowitz
lymphoma therapeutics
Stephen Oh
myeloproliferative neoplasms
Ana Vujovic
AML
Jonathan Licht
DNA biology, myeloma
Ann-Kathrin Eisfeld
Racial diversity in AML
Adam de Smith
pediatric ALL and Down Syndrome
Paolo Caimi
CAR-T clinical trial for CLL
Courtney DiNardo
clinical trials, AML
Ari Melnick
epigenetics and lymphoma
Christian Marinaccio
MLL leukemias
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Tyler Parsons
MPN and AML
Madhav Dhodapkar
multiple myeloma immunotherapy
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Hong Wen
AML
Hao Jiang
DNA biology and leukemia
Mark Dawson
B-ALL and CAR-T resistance
Wendy Stock
T-cell ALL
James Rubenstein
Lymphoma of the Central Nervous System
Stephen Gottschalk
pediatric leukemia and CAR-T
Ravi Bhatia
transplantation
Koichi Takahashi
AML/MDS
Qingyu Luo
BPDCN
Daisuke Nakada
preleukemia, leukemia
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Steven Horwitz
T-cell lymphomas
Marina Konopleva
MDS/AML metabolism
Thorsten Zenz
Hairy cell leukemia
Michael Kharas
leukemia
Bailee Kain
AML and African ancestry
Marco Ruella
Immunotherapy for T-cell lymphoma
Catherine Smith
leukemia
Peter Klein
MDS
Simona Colla
Myeloma biology
Faron Pharmaceuticals
immunotherapy, MDS
Meng Li
Equity in Access
Sisi Chen
leukemia
Taishi Yonezawa
AML
Liling Wan
AML
Randall Davis
CLL
Liran Shlush
pre-leukemia
Justine Kahn
pediatric leukemia and lymphoma
Tycel Phillips
Mantle Cell Lymphoma
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Huda Salman
CMML
Alexey Danilov
lymphoma
Mark Hamilton
DLBCL and CAR-T
Yoke Seng Lee
AML
Peter Croucher
Multiple Myeloma
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Christopher Porter
Leukemia, lymphoma
Jeffrey Magee
pediatric AML
Shazia Nakhoda
Equity in Access
Mala Shanmugam
myeloma
Matthew Frank
Lymphoma CART therapy
John DiPersio
trispecific antibody for AML and MDS
Eric Pietras
AML
Jake Shortt
precision therapy for aggressive lymphomas
Jing Fu
myeloma
Jennifer Trowbridge
aging and leukemia
Ricky Johnstone
lymphoma and myeloma
Armin Rashidi
gut bacteria and transplant success
Enterome
vaccine, FL, MZL
Piers Patten
COVID-19
Enrico Tiacci
Hairy cell leukemia
Alec Zhang
myeloma, immunotherapy
Jenny Wang
AML
Gaurav Goyal
Erdheim-Chester Disease
Lucy Godley
preleukemia
Roland Walter
Antibody-based AML therapies
Fahmin Basher
transplant and GvHD
Mendel Goldfinger
MDS/AML trials for the elderly
Jianguo Tao
Mantle Cell Lymphoma
Tomasz Skorski
myeloproliferative neoplasms, AML
Jennifer Lewis
URM Student
Jaroslaw Maciejewski
bone marrow failure
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Affimed
immunotherapy, HL, PTCL
Alieen Rowan
Adult T cell leukemia/lymphoma
Lakshmi Nayak
brain tumors in lymphoma
Kerry Rogers
CLL
Noemí Puig Morón
Myeloma
Sarah Tasian
pediatric leukemias
Maximilian Stahl
AML immunotherapy
Jayna Mistry
aging and leukemias
Fenghuang Zhan
Myeloma and bone disease
Pooja Khandelwal
bone marrow transplantation
John Leonard
lymphoma research
Robert Orlowski
(Smoldering) Multiple Myeloma
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Kathleen Sakamoto
pediatric AML
Raymond Mailhot
Equity in Access
Steven Park
follicular lymphoma
Michael Savona
MDS and leukemia
Daniel Thomas
Myelofibrosis
Michael Keller
COVID-19, immunotherapy
George Daley
"off-the-shelf" CAR-T and CAR-NK
Megan McNerney
AML/MDS
Lindsey Montefiori
pediatric leukemia
Grzegorz Nowakowski
Clinical trial access
Susan Schwab
cancer immunology
Logan Spector
childhood leukemia epidimiology
Julia Maxson
AML
Thomas LeBlanc
palliative care
Stacie Dusetzina
Equity in Access
William Matsui
Myeloma
Siddhartha Jaiswal
preleukemia
Nirav Shah
CAR-T for lymphoma
Daniel Herranz
T-ALL
Brian Walker
smoldering myeloma, MGUS
Nicoletta Cieri
AML and transplantation
Michael Wang
Mantle Cell Lymphoma
Christian Steidl
B-cell lymphomas
F. Lennie Wong
Equity in Access
Carl June
CAR T immunotherapy
Sham Mailankody
Myeloma immunotherapy clinical trials
Frederick Locke
lymphoma and immunotherapy
Paul Beavis
immunotherapy in myeloma
Roberta Zappasodi
lymphoma, immunotherapy
Tak Mak
Immunotherapy
Craig Jordan
AML
Teresa Palomero
Peripheral T-cell Lymphoma
Sergei Doulatov
Leukemias
Amin Sobh
Myeloma biology
Timothy Graubert
AML and MDS biology
Soheil Meshinchi
pediatric AML
Sheng Li
Aging and AML
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Carma Bylund
Equity in Access
Ruben Carrasco
Myeloma
Jing Yang
Myeloma
Jennifer Woyach
CLL trials
Bruno Paiva
smoldering myeloma
Qing Yi
Novel CAR-T
Daniel Pollyea
AML
Yubin Zhou
peripheral T cell lymphoma
Neha Mehta-Shah
T-cell lymphoma
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Thomas Koehnke
leukemia
Kura Oncology
MLL leukemia, AML
Matteo Bellone
Smoldering multiple myeloma
Yibin Yang
Lymphoma
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Jeetayu Biswas
splicing in myeloid diseases
Saar Gill
AML immunotherapy
Riccardo Dalla-Favera
lymphoma (DLBCL)
Margaret Shipp
lymphoma biology
Richard Lock
T-ALL
Arash Alizadeh
blood cancer biology and diagnosis
Grant Challen
preleukemia, leukemia
Gareth Morgan
smoldering myeloma, MGUS
Britta Will
Leukemia and pre-leukemia
Steven Treon
Lymphomas and Waldenstrom's
Bingyi Chen
AML immunotherapy
Caner Saygin
T-ALL
Frederike Kramer
MPNs
Anouchka Laurent
T-cell lymphoma
Lori Muffly
Equity in Access
Kirk Schultz
pediatric transplantation
Carl Allen
pediatric blood cancers
Markus Muschen
leukemia and lymphoma biology
Ryan Wilcox
T-cell lymphoma
Nizar Bahlis
Myeloma immunotherapy
Brian Dalton
DNA mutations and myeloid cancers
H. Irene Su
Equity in Access
Adam Olszewski
Follicular and marginal zone lymphoma
Sriram Sundaravel
AML stem cells
Jolanta Grembecka
leukemia therapeutics
Rgenta Therapeutics
RNA-targeting, blood cancer
Jun Qi
Myeloma
Venkata Lokesh Battula
immunotherapy and AML
Adi Nagler
Bronchiolitis obliterans after transplant
Ronald Levy
immunotherapies, COVID-19
Christopher Flowers
clinical trial access
Gianpietro Dotti
CAR T and AML
Yiman Liu
Epigenetics and leukemia
Stephen Nimer
myeloid cancer biology
Ramon Massoni-Badosa
CLL and Richter's Syndrome